Quality of Life in Patients With Primary Sclerosing Cholangitis

Completed · Not applicable

Conditions studied: Primary Sclerosing Cholangitis

In brief

The purpose of this study is to assess the healthcare-related quality of life (HRQOL), the impact of risk of liver transplant and risk of malignancy on HRQOL, and the complementary and alternative medicine use in patients with PSC.

Key facts

Study ID

NCT02712736

Run by

Duke University

People needed

102

Starts

2016-07-01

Expected to finish

2018-09-22

Last updated by the study team

2020-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age ≥ 18) patients with PSC, confirmed by laboratory tests, imaging, and/or liver biopsy

You may not qualify if…

• Patients <18
• Patients who have undergone liver transplant, patients with frank hepatic encephalopathy
• Patients with active inflammatory bowel disease (IBD) flares
• Patients with malignancies
• Patients unable to understand English
• Patients refusing to participate or provide informed consent

Where it is running

• Duke University — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.